Analysis of Oncogene Amplification and C-Myc Overexpression in Human Ovarian Cancer
| Project/Area Number |
01571283
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Experimental pathology
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
FUKUMOTO Manabu Fac. Medicine, Dept. Pathology. Instructor, 医学部, 助手 (60156809)
|
|---|
| Project Period (FY) |
1989 – 1990
|
| Project Status |
Completed (Fiscal Year 1990)
|
| Budget Amount *help |
¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1990: ¥1,200,000 (Direct Cost: ¥1,200,000)
|
|---|
| Keywords | Human Tumor / Ovarian Cancer / Oncogene / Gene Amplification / Gene Expression / Tumor Tissue / C-myc |
|---|
| Research Abstract |
Amplification and expression of oncogenes were investigated in 55 cases of human ovarian cancer tissues. Gene amplificaion of unknown nature was screened by in-gel renaturation assay and amplification of the c-myc, Ki-ras and neu oncogenes were determined by Southern blot hybridization. No significant gene amplification was found in all the cases. By Northern hybridization assay, the c-myc gene was overexpressed in 29 cases (52.7%) whereas either k-ras or neu was not.
The overexpression more than 3-fold of the c-myc gene was significant in serous cystadenocarcinoma and endometrioid carcinoma tissues compared with other histological types of tumor. Immunohistochemistry and in-situ hybridization revealed that tumor cells overexpressed both the c-myc gene and the protein.
Although the expression level was not related to grading of malignancy, it is suggested that the c-myc gene is involved in early stages of carcinogesis of ovarian tumors.
|
Report
(3 results)
Research Products
(19 results)
